A Study to Evaluate the Effect of Ustekinumab on Cytochrome P450 Enzyme Activities Following Induction and Maintenance Dosing in Participants With Active Crohn's Disease or Ulcerative Colitis
Clinical trial NCT03358706 · TERMINATED
Trial details
- NCT number
- NCT03358706
- Sponsor
- Janssen Research & Development, LLC
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-02
- Primary completion
- 2021-11-22
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.